Sorafenib combined vitamin K induces apoptosis in human pancreatic cancer cell lines through RAF/MEK/ERK and c-Jun NH2-terminal kinase pathways.
about
A novel berbamine derivative inhibits cell viability and induces apoptosis in cancer stem-like cells of human glioblastoma, via up-regulation of miRNA-4284 and JNK/AP-1 signalingCantharidin Induced Oral Squamous Cell Carcinoma Cell Apoptosis via the JNK-Regulated Mitochondria and Endoplasmic Reticulum Stress-Related Signaling PathwaysVitamin K1 exerts antiproliferative effects and induces apoptosis in three differently graded human colon cancer cell lines.Metabolic Profiling Comparison of Human Pancreatic Ductal Epithelial Cells and Three Pancreatic Cancer Cell Lines using NMR Based Metabonomics.Systematic drug repositioning through mining adverse event data in ClinicalTrials.govA novel synthetic derivative of the natural product berbamine inhibits cell viability and induces apoptosis of human osteosarcoma cells, associated with activation of JNK/AP-1 signaling.Vitamins in pancreatic cancer: a review of underlying mechanisms and future applications.Sorafenib sensitizes hepatocellular carcinoma cells to physiological apoptotic stimuli.IGF-1R tyrosine kinase inhibitors and Vitamin K1 enhance the antitumor effects of Regorafenib in HCC cell lines.
P2860
Q28537845-B4837D43-3ACF-47E2-A409-166E120C80F2Q28554836-BE851903-63BB-4F0E-9D52-C0C09FABD43FQ35667854-E8B72BE6-77AC-45C8-AD7E-B240C38EF88BQ36307024-77C3A3B4-1C2A-4819-85C2-B4EC75214329Q36324867-EF3AB340-379C-463A-B682-67E6E522BDF6Q37586898-58C303F9-8575-498E-BF89-8B7D6D2B6272Q38633074-64E2AD15-38E9-405D-8DDA-0831780F883CQ39499156-FB0D2CA4-EB3A-4BED-9B2A-8BA4274BF7FFQ47101174-A4EA582C-F2C4-436C-B0FE-B047CA81B502
P2860
Sorafenib combined vitamin K induces apoptosis in human pancreatic cancer cell lines through RAF/MEK/ERK and c-Jun NH2-terminal kinase pathways.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Sorafenib combined vitamin K i ...... NH2-terminal kinase pathways.
@en
Sorafenib combined vitamin K i ...... NH2-terminal kinase pathways.
@nl
type
label
Sorafenib combined vitamin K i ...... NH2-terminal kinase pathways.
@en
Sorafenib combined vitamin K i ...... NH2-terminal kinase pathways.
@nl
prefLabel
Sorafenib combined vitamin K i ...... NH2-terminal kinase pathways.
@en
Sorafenib combined vitamin K i ...... NH2-terminal kinase pathways.
@nl
P2860
P356
P1476
Sorafenib combined vitamin K i ...... n NH2-terminal kinase pathways
@en
P2093
Meifang Wang
P2860
P304
P356
10.1002/JCP.22099
P577
2010-07-01T00:00:00Z